Proprotein convertase subtilisin/kexin type 9 inhibitors in secondary prevention of vascular events in patients with stroke: Consensus document and practice guidance
Antonio Gil-Núñez(Hospital General Universitario Gregorio Marañón), E. Palacio(Marqués de Valdecilla University Hospital), P. Cardona(Bellvitge University Hospital), José Ignacio Tembl, Joan Montaner(Universitat Autònoma de Barcelona), Mar Castellanos(Universidade da Coruña), Juan F. Arenillas(Universidad de Valladolid), Tomás Segura(Complejo Hospitalario Universitario de Albacete), Francisco Purroy(Hospital Universitari Arnau de Vilanova), Jaime Masjuán(Universidad de Alcalá)
Cited by 3
Related Papers
Treatment for Adult HIV Infection
|JAMA|2006|1k
Antiretroviral Therapy in Adults
|JAMA|2000|1k
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2008|1k
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source
|New England Journal of Medicine|2019|823
Treatment for Adult HIV Infection
|JAMA|2004|737